Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models

Some antibacterial therapies entail sequential treatments with different antibiotics, but whether this approach is optimal for anti‐cancer tyrosine kinase inhibitors (TKIs) remains open. EGFR mutations identify lung cancer patients who can derive benefit from TKIs, but most patients develop resistan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EMBO Mol Med
Main Authors: Marrocco, Ilaria, Romaniello, Donatella, Vaknin, Itay, Drago‐Garcia, Diana, Oren, Roni, Uribe, Mary Luz, Belugali Nataraj, Nishanth, Ghosh, Soma, Eilam, Raya, Salame, Tomer‐Meir, Lindzen, Moshit, Yarden, Yosef
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8033519/
https://ncbi.nlm.nih.gov/pubmed/33660397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202013144
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados